{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:44:12Z","timestamp":1793951052124,"version":"4.8.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T00:00:00Z","timestamp":1583193600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019328","name":"NGM Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 23239"],"award-info":[{"award-number":["IG 23239"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["MIS5003627"],"award-info":[{"award-number":["MIS5003627"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ebiom.2020.102719","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T23:22:28Z","timestamp":1586042548000},"page":"102719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"special_numbering":"C","title":["Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor"],"prefix":"10.1016","volume":"54","author":[{"given":"Raffaella Maria","family":"Gadaleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oihane","family":"Garcia-Irigoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marica","family":"Cariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Scialpi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Peres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gionatha","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Porru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Roda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sabb\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2123-6074","authenticated-orcid":false,"given":"Antonio","family":"Moschetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102719_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s42255-019-0074-3","article-title":"Metabolic Messengers: fibroblast growth factor 15\/19","author":"Gadaleta","year":"2019","journal-title":"Nature Metabolism"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102719_bib0002","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nm1501","article-title":"Identification of a hormonal basis for gallbladder filling","volume":"12","author":"Choi","year":"2006","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.ebiom.2020.102719_bib0003","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102719_bib0004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0005","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology"},{"issue":"5418","key":"10.1016\/j.ebiom.2020.102719_bib0006","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"5418","key":"10.1016\/j.ebiom.2020.102719_bib0007","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102719_bib0008","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0009","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbalip.2014.08.005","article-title":"Tissue-specific actions of FXR in metabolism and cancer","volume":"1851","author":"Gadaleta","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00010.2008","article-title":"Role of bile acids and bile acid receptors in metabolic regulation","volume":"89","author":"Lefebvre","year":"2009","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102719_bib0011","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/oby.2009.102","article-title":"Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism","volume":"17","author":"Patti","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0012","doi-asserted-by":"crossref","first-page":"17210","DOI":"10.1038\/s41598-018-35496-z","article-title":"Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis","volume":"8","author":"Gadaleta","year":"2018","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102719_bib0013","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102719_bib0014","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2012-302578","article-title":"Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases","volume":"62","author":"Duboc","year":"2013","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102719_bib0015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102719_bib0016","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/ibd.21502","article-title":"Bile acid malabsorption in inflammatory bowel disease: assessment by serum markers","volume":"17","author":"Lenicek","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1586\/egh.12.66","article-title":"Altered enterohepatic circulation of bile acids in Crohn's disease and their clinical significance: a new perspective","volume":"7","author":"Nolan","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.ebiom.2020.102719_bib0018","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrgastro.2014.32","article-title":"Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy","volume":"11","author":"Walters","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102719_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI105722","article-title":"Bile salt malabsorption in regional ileitis, ileal resection and mannitol-induced diarrhea","volume":"47","author":"Meihoff","year":"1968","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.53.1.78","article-title":"Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor","volume":"53","author":"Jung","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0021","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/gut.53.1.10","article-title":"Do steroids ameliorate bile acid malabsorption in Crohn's disease?","volume":"53","author":"Kwon","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2020.102719_bib0022","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.M700351-JLR200","article-title":"FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption","author":"Jung","year":"2007","journal-title":"Journal of Lipid Research"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102719_bib0023","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102719_bib0024","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102719_bib0025","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.0600780103","article-title":"How bile acids confer gut mucosal protection against bacteria","volume":"103","author":"Hofmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102719_bib0026","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","article-title":"Bile acid is a host factor that regulates the composition of the cecal microbiota in rats","volume":"141","author":"Islam","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102719_bib0027","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1517\/14712598.2014.880420","article-title":"The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention","volume":"14","author":"Jones","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ebiom.2020.102719_bib0028","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/398585","article-title":"The interplay of the gut microbiome, bile acids, and volatile organic compounds","volume":"2015","author":"Sagar","year":"2015","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102719_bib0029","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.ebiom.2020.102719_bib0030","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1038\/ncomms5573","article-title":"PPARalpha-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis","volume":"5","author":"Zhou","year":"2014","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102719_bib0031","doi-asserted-by":"crossref","first-page":"e49706","DOI":"10.1371\/journal.pone.0049706","article-title":"Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis","volume":"7","author":"van Schaik","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102719_bib0032","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.4049\/jimmunol.0803978","article-title":"The bile acid receptor FXR is a modulator of intestinal innate immunity","volume":"183","author":"Vavassori","year":"2009","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102719_bib0033","doi-asserted-by":"crossref","first-page":"e36713","DOI":"10.1371\/journal.pone.0036713","article-title":"Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models","volume":"7","author":"French","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2020.102719_bib0034","doi-asserted-by":"crossref","first-page":"e52711","DOI":"10.1371\/journal.pone.0052711","article-title":"Regulation of amphiregulin gene expression by beta-catenin signaling in human hepatocellular carcinoma cells: a novel crosstalk between FGF19 and the EGFR system","volume":"7","author":"Latasa","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102719_bib0035","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","article-title":"A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice","volume":"160","author":"Nicholes","year":"2002","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102719_bib0036","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2011.01.040","article-title":"Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening","volume":"19","author":"Sawey","year":"2011","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102719_bib0037","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.22771","article-title":"High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis","volume":"49","author":"Schaap","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102719_bib0038","doi-asserted-by":"crossref","first-page":"e17868","DOI":"10.1371\/journal.pone.0017868","article-title":"FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"issue":"32","key":"10.1016\/j.ebiom.2020.102719_bib0039","doi-asserted-by":"crossref","first-page":"14158","DOI":"10.1073\/pnas.1009427107","article-title":"Separating mitogenic and metabolic activities of fibroblast growth factor 19 (FGF19)","volume":"107","author":"Wu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102719_bib0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0378-4347(94)00544-F","article-title":"High-performance liquid chromatographic-electrospray mass spectrometric analysis of bile acids in biological fluids","volume":"665","author":"Roda","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102719_bib0041","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.intimp.2008.01.036","article-title":"Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease","volume":"8","author":"Melgar","year":"2008","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102719_bib0042","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1053\/j.gastro.2007.02.056","article-title":"Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function","volume":"132","author":"Cario","year":"2007","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102719_bib0043","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142334","article-title":"The Characterization of novel tissue microbiota using an optimized 16S metagenomic sequencing pipeline","volume":"10","author":"Lluch","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102719_bib0044","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/bioinformatics\/btx791","article-title":"FROGS: find, rapidly, OTUs with galaxy solution","volume":"34","author":"Escudie","year":"2018","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102719_bib0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/ajcp\/63.3.359","article-title":"Mucosal-cell counts in ulcerative and granulomatous colitis","volume":"63","author":"Sommers","year":"1975","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102719_bib0046","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/0016-5085(93)90668-3","article-title":"Permeability in Crohn's disease: altered barrier functions in healthy relatives?","volume":"104","author":"Hollander","year":"1993","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102719_bib0047","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0016-5085(97)70174-4","article-title":"Clustering of increased small intestinal permeability in families with Crohn's disease","volume":"113","author":"Peeters","year":"1997","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102719_bib0048","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1242\/dev.070722","article-title":"Cdx2 determines the fate of postnatal intestinal endoderm","volume":"139","author":"Stringer","year":"2012","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102719_bib0049","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ydbio.2010.11.001","article-title":"Altered intestinal epithelial homeostasis in mice with intestine-specific deletion of the Kruppel-like factor 4 gene","volume":"349","author":"Ghaleb","year":"2011","journal-title":"Dev Biol"},{"issue":"4","key":"10.1016\/j.ebiom.2020.102719_bib0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1521-1878(199804)20:4<336::AID-BIES10>3.0.CO;2-3","article-title":"Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem","volume":"20","author":"Hooper","year":"1998","journal-title":"Bioessays"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102719_bib0051","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.3748\/wjg.v22.i11.3117","article-title":"Tight junctions in inflammatory bowel diseases and inflammatory bowel disease associated colorectal cancer","volume":"22","author":"Landy","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ebiom.2020.102719_bib0052","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"issue":"23","key":"10.1016\/j.ebiom.2020.102719_bib0053","doi-asserted-by":"crossref","first-page":"9589","DOI":"10.1158\/0008-5472.CAN-08-1791","article-title":"Nuclear bile acid receptor FXR protects against intestinal tumorigenesis","volume":"68","author":"Modica","year":"2008","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102719_bib0054","doi-asserted-by":"crossref","first-page":"e23745","DOI":"10.1371\/journal.pone.0023745","article-title":"Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease","volume":"6","author":"Nijmeijer","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ebiom.2020.102719_bib0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1002\/bjs.1800811122","article-title":"Classification of the sequelae of bowel resection for Crohn's disease","volume":"81","author":"Cosnes","year":"1994","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102719_bib0056","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2006.05.002","article-title":"c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter","volume":"131","author":"Neimark","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102719_bib0057","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ecco-jcc\/jju022","article-title":"Diarrhea in Crohn's disease: investigating the role of the ileal hormone fibroblast growth factor 19","volume":"9","author":"Nolan","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"2","key":"10.1016\/j.ebiom.2020.102719_bib0058","doi-asserted-by":"crossref","first-page":"G163","DOI":"10.1152\/ajpgi.00276.2013","article-title":"c-Fos mediates repression of the apical sodium-dependent bile acid transporter by fibroblast growth factor-19 in mice","volume":"306","author":"Ghosh","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"10.1016\/j.ebiom.2020.102719_bib0059","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1097\/MIB.0000000000000879","article-title":"Alterations in enterohepatic Fgf15 signaling and changes in bile acid composition depend on localization of murine intestinal inflammation","volume":"22","author":"Rau","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102719_bib0060","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","article-title":"FXR regulates intestinal cancer stem cell proliferation","volume":"176","author":"Fu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102719_bib0061","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.3389\/fmicb.2018.03002","article-title":"Non-isoflavones diet incurred metabolic modifications induced by constipation in rats via targeting gut microbiota","volume":"9","author":"Liu","year":"2018","journal-title":"Front Microbiol"},{"issue":"25","key":"10.1016\/j.ebiom.2020.102719_bib0062","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.3748\/wjg.v23.i25.4548","article-title":"Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"23","author":"Bajer","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.ebiom.2020.102719_bib0063","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","article-title":"A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis","volume":"63","author":"Machiels","year":"2014","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ebiom.2020.102719_bib0064","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12906-016-1456-7","article-title":"Sasa quelpaertensis leaf extract regulates microbial dysbiosis by modulating the composition and diversity of the microbiota in dextran sulfate sodium-induced colitis mice","volume":"16","author":"Yeom","year":"2016","journal-title":"BMC Complement Altern Med"},{"issue":"10126","key":"10.1016\/j.ebiom.2020.102719_bib0065","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(18)30474-4","article-title":"NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"391","author":"Harrison","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ebiom.2020.102719_bib0066","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jhep.2018.10.035","article-title":"Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: a multicenter, randomized, double-blind, placebo-controlled phase II trial","volume":"70","author":"Hirschfield","year":"2019","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.ebiom.2020.102719_bib0067","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/hep4.1209","article-title":"NGM282 for treatment of patients with primary biliary cholangitis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"2","author":"Mayo","year":"2018","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.ebiom.2020.102719_bib0068","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41395-018-0042-7","article-title":"Effects of NGM282, an FGF19 variant, on colonic transit and bowel function in functional constipation: a randomized phase 2 trial","volume":"113","author":"Oduyebo","year":"2018","journal-title":"Am J Gastroenterol"}],"updated-by":[{"DOI":"10.1016\/j.ebiom.2020.102873","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000}}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420300943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:59:41Z","timestamp":1762455581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420300943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":68,"alternative-id":["S2352396420300943"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102719","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102719"}}